Hepatitis B virus infection--natural history and clinical consequences
about
Protein X of hepatitis B virus: origin and structure similarity with the central domain of DNA glycosylasePharmacological treatments for acute hepatitis B infection: a network meta-analysisPharmacological treatments for chronic hepatitis B liver disease: a network meta-analysisInterferon alpha for chronic hepatitis BCombined DTP-HBV vaccine versus separately administered DTP and HBV vaccines for primary prevention of diphtheria, tetanus, pertussis, and hepatitis BRole of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1Clinical features of chronic hepatitis B patients with YMDD mutation after lamivudine therapy.Hepatitis B virus replicationThe role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic useTargeted DNA mutagenesis for the cure of chronic viral infectionsEmerging infectious determinants of chronic diseasesRole of bacteria in oncogenesisA genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype JViruses associated with human cancerFine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interactionProperties of subviral particles of hepatitis B virusHBV pathogenesis in animal models: recent advances on the role of plateletsHepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptinInterferon and lamivudine vs. interferon for hepatitis B e antigen-positive hepatitis B treatment: meta-analysis of randomized controlled trialsTranslation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotidesRole of the microbiome in non-gastrointestinal cancersAdvances and Challenges in Studying Hepatitis B Virus In VitroControversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinomaMicroRNAs Expressed during Viral Infection: Biomarker Potential and Therapeutic ConsiderationsThe Role of Immune Cells in Chronic HBV InfectionApplication of CRISPR/Cas9 Technology to HBVUpdate on Hepatitis B Virus Infection: Focus on TreatmentImmune-mediated Liver Injury in Hepatitis B Virus InfectionMicrovesicles and viral infectionMolecular mechanism of hepatitis B virus-induced hepatocarcinogenesisCurrent and future directions for treating hepatitis B virus infectionMouse models of hepatitis B virus infection comprising host-virus immunologic interactionsManagement of chronic hepatitis B infection: current treatment guidelines, challenges, and new developmentsPotential mechanisms of hepatitis B virus induced liver injuryFoamy virus budding and releasePersistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factorsLambda interferon inhibits hepatitis B and C virus replication.Stealth and cunning: hepatitis B and hepatitis C viruses.Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cellsSynthesis and Anti-Hepatitis B Virus and Anti-Hepatitis C Virus Activities of 7-Deazaneplanocin A Analogues in Vitro
P2860
Q21089944-C95AC40D-3A63-480B-86B9-1E33A7678F62Q24186837-02F66687-FF6D-4923-8A92-BD5DF2D04821Q24186878-3BC59366-E4FF-4C4B-AB88-A9B26FF51783Q24235232-0484E625-36B0-4C13-8221-8395FDBD3119Q24236040-9F71963C-205B-487D-833F-B3DD43E7A642Q24320028-7E793360-57D4-4698-8325-762CE6201B3EQ24542846-6A8EE9A4-B737-4F5B-884C-B0A7798F8DC3Q24563894-92CBDA87-3535-42E1-B169-ED8E72B4E9CBQ24599103-F419734C-09B4-4813-B565-7062307CB96AQ24620150-161E4D96-0F3F-4B4A-821D-9BD83B5D0C7BQ24628832-571EA7B6-C431-4128-9486-E2B2F35DA2F5Q24633180-DB4FD244-7F65-431D-907D-8A2ED7DD06BBQ24646080-B1E7D645-9228-4C59-A9A7-54B982BB9C94Q24653900-4F110737-9D36-4756-A2AF-44B67AE009F9Q24656570-0FDF44E1-F774-43B8-A96C-D8E23D94F44EQ24658234-C85AD76B-23BE-4A43-B00D-8A884D21B531Q24672103-065CDBB5-088A-4030-B39F-C4F84F312267Q24676087-EA7FC2E7-02F8-40C1-956E-226926C7D8FAQ24683341-E3F47F25-89EE-467E-9201-0DF71E34B561Q24793675-A0641A4A-0C0A-401C-90B1-3AEEE0C9A716Q26747710-82DAB48B-2E2D-4E09-BE4F-B8A3261DE38AQ26771134-44703B1B-920F-44E7-A935-69868F84BF5DQ26772324-FED7761A-0E3C-4716-975E-C1C185249AF4Q26773183-B32A21FD-B119-448C-B124-E5E98FA5DA36Q26774875-B93BCDD8-0D6C-427B-8519-1232D65AFC73Q26779150-3EB005DF-9C69-4430-8F43-691D219E6975Q26781990-3493541B-BC9E-40B5-9350-2D7DA1DDC246Q26786772-0DF570E6-0BFA-46E2-9662-0A9CB85F30F7Q26823408-380654A7-D321-4D28-93FA-74DAC8C7FD09Q26823512-F5549B0E-DFBA-430D-874E-8EE1CC1AA2C9Q26851240-94D010B7-0598-49B7-AAC4-C7A20F9732ACQ27002598-0485E64B-E600-44DD-80B6-4F22220401FFQ27008984-ED54189B-8B39-46AD-B843-0D79EFB0658BQ27014079-39C0B342-F5D5-4927-B6C9-34FA491D5B67Q27015997-47E80DDC-B624-45FB-86BD-5439488E1C1FQ27302970-02A266E7-ACB1-4236-8E07-D7048641869BQ27469456-B98BB53E-D229-40D5-A019-BA8CD99CCE8AQ27470232-0EAF5423-4ACC-45D0-811C-A98F635DE22EQ27489094-8EE91CDB-F1C0-43DF-BFD8-72505AAE47DEQ27489125-3178BCEB-D3D9-4A30-AC66-03FC31D9D1A4
P2860
Hepatitis B virus infection--natural history and clinical consequences
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Hepatitis B virus infection--natural history and clinical consequences
@ast
Hepatitis B virus infection--natural history and clinical consequences
@en
type
label
Hepatitis B virus infection--natural history and clinical consequences
@ast
Hepatitis B virus infection--natural history and clinical consequences
@en
prefLabel
Hepatitis B virus infection--natural history and clinical consequences
@ast
Hepatitis B virus infection--natural history and clinical consequences
@en
P3181
P356
P1476
Hepatitis B virus infection--natural history and clinical consequences
@en
P2093
P304
P3181
P356
10.1056/NEJMRA031087
P407
P50
P577
2004-03-11T00:00:00Z